SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-323794
Filing Date
2013-08-07
Accepted
2013-08-07 13:59:16
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d547025d10q.htm 10-Q 399470
2 EX-31.1 d547025dex311.htm EX-31.1 9313
3 EX-31.2 d547025dex312.htm EX-31.2 9238
4 EX-32.1 d547025dex321.htm EX-32.1 2648
5 EX-32.2 d547025dex322.htm EX-32.2 2650
  Complete submission text file 0001193125-13-323794.txt   3880504

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20130630.xml EX-101.INS 314537
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20130630.xsd EX-101.SCH 33259
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20130630_cal.xml EX-101.CAL 39866
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20130630_def.xml EX-101.DEF 178705
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20130630_lab.xml EX-101.LAB 255890
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20130630_pre.xml EX-101.PRE 207891
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 131016874
SIC: 2834 Pharmaceutical Preparations